Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19” - ScienceDirect
Sexual Dysfunction in the Context of hEDS, MCAS, and POTS: A Cross-Sectional Analysis in a Community-Based Population | The Journal of Sexual Medicine | Oxford Academic